NF2-related schwannomatosis: A view from within the inner ear

被引:0
|
作者
Brown, Eleanor D. [1 ]
Nassar, Shada [1 ]
Jagger, Daniel J. [1 ]
机构
[1] UCL, UCL Ear Inst, 332 Grays Inn Rd, London WC1X 8EE, England
关键词
Cochlea; Hearing loss; Meningioma; Neurofibromatosis; Schwannoma; BILATERAL ACOUSTIC NEUROFIBROMATOSIS; VESTIBULAR SCHWANNOMAS; EARLY HISTORY; TYPE-2; DEAFNESS; NEUROMA; FAMILY; NF2;
D O I
10.1016/j.heares.2025.109226
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
NF2-related schwannomatosis (NF2-SWN, formerly known as neurofibromatosis type 2) is an autosomal dominant disorder associated with the growth of bilateral schwannomas on the cochleo-vestibular nerves and meningiomas. NF2-SWN is caused by pathogenic variations in the NF2, moesin-ezrin-radixin-like (MERLIN) tumour suppressor gene. The mostly benign tumours can cause progressive sensorineural hearing loss, tinnitus and balance dysfunction. Outside the inner ear, tumours grow on other intra-cranial nerves, leading to further neurological issues and shortened life-expectancy. Here we re-evaluate some historic cases from our human temporal bone collection, and we review similar instances from the literature to highlight the structural and functional effects of such tumours on the cochlea and vestibular organs. Tumour growth is associated with the remodelling of sensory and ion-transporting epithelia, the loss of afferent neurons and hair cells, and signs of fluid dysregulation. These cases demonstrate the aggressive nature of this disease and the difficulties of surgically excising the bilateral tumours. They also emphasise the need for novel therapies that can slow or prevent tumour growth to preserve sensory function in people living with NF2-SWN.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] INTUITT-NF2, AN ADAPTIVE PLATFORM-BASKET TRIAL FOR NF2-RELATED SCHWANNOMATOSIS PATIENTS WITH PROGRESSIVE SCHWANNOMAS, MENINGIOMAS, AND EPENDYMOMAS: PRIMARY OUTCOME OF THE BRIGATINIB TREATMENT ARM
    Plotkin, Scott R.
    Babovic-Vuksanovic, Dusica
    Dinh, Christine
    Fell, Geoffrey
    Merker, Vanessa
    Nghiemphu, Phioanh
    Trippa, Lorenzo
    Yohay, Kaley
    Blakeley, Jaishri
    NEURO-ONCOLOGY, 2023, 25
  • [42] ACTIVITY OF BEVACIZUMAB AGAINST NF2-RELATED VESTIBULAR SCHWANNOMAS
    Plotkin, Scott
    Halpin, Christopher
    Stemmer-Rachamimov, Anat
    Barker, Fred
    Sorensen, Gregory
    Jain, Rakesh
    Di Tomaso, Emmanuelle
    NEURO-ONCOLOGY, 2008, 10 (05) : 796 - 796
  • [43] DEFINING THE SMALLEST WORTHWHILE EFFECT OF TREATMENT FOR PROGRESSIVE NERVOUS SYSTEM TUMORS IN PEOPLE WITH NF2-RELATED SCHWANNOMATOSIS: QUALITATIVE PATIENT INTERVIEW RESULTS FROM A MULTICENTER CLINICAL TRIAL
    Merker, V
    Von Imhof, L.
    Park, E. R.
    Babovic-Vuksanovic, D.
    Nghiemphu, P. L.
    Yohay, K. H.
    Plotkin, S. R.
    VALUE IN HEALTH, 2023, 26 (06) : S326 - S327
  • [44] PREDICTING THE CLINICAL PHENOTYPE IN NF2 RELATED SCHWANNOMATOSIS PATIENTS
    Borghi, Arianna
    Rosati, Nayma
    Paterra, Rosina
    Vetrano, Igrazio
    Nazzi, Vittoria
    Moscatelli, Marco
    Silvani, Antonio
    Eoli, Marica
    NEURO-ONCOLOGY, 2023, 25
  • [45] Uncovering cellular senescence as a therapeutic target in NF2-related vestibular schwannoma
    Franco-Caspuenas, Sandra
    Garcia-Montoya, Carmen
    Contreras, Julio
    Lassaletta, Luis
    Varela-Nieto, Isabel
    Jimenez-Lara, Ana M.
    HEARING RESEARCH, 2025, 455
  • [46] TAM receptors as potential therapeutic targets in NF2-related schwannomas and meningiomas
    Dave, Foram
    Ammoun, Sylwia
    Hanemann, C. Oliver
    CANCER RESEARCH, 2021, 81 (13)
  • [47] Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy
    Scott R Plotkin
    Marybeth A Singh
    Caroline C O'Donnell
    Gordon J Harris
    Andrea I McClatchey
    Chris Halpin
    Nature Clinical Practice Oncology, 2008, 5 : 487 - 491
  • [48] Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy
    Plotkin, Scott R.
    Singh, Marybeth A.
    O'Donnell, Caroline C.
    Harris, Gordon J.
    McClatchey, Andrea I.
    Halpin, Chris
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (08): : 487 - 491
  • [49] Correlation between natural history and multi-omics profiling of meningiomas in NF2-related schwannomatosis suggests role of methylation group and immune microenvironment in tumor growth rate
    Teranishi, Yu
    Yurchenko, Andrey
    Tran, Suzanne
    Sievers, Philipp
    Rajabi, Fatemeh
    Ruchith, Singhabahu
    Abi-Jaoude, Samiya
    Blouin, Antoine
    Bielle, Franck
    Cazals-Hatem, Dominique
    Sahm, Felix
    Nikolaev, Sergey
    Kalamarides, Michel
    Peyre, Matthieu
    ACTA NEUROPATHOLOGICA, 2024, 148 (01)
  • [50] Correlation between VEGF expression and MVD in sporadic and NF2-related schwannomas
    Ditomaso, E.
    Stemmer-Rachamimov, A.
    Potts, A.
    Drottar, M.
    Jain, R. K.
    Plotkin, S. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)